Kestra Medical Technologies, Ltd. Common Stock (KMTS)vsResMed Inc (RMD)
KMTS
Kestra Medical Technologies, Ltd. Common Stock
$27.24
-5.02%
HEALTHCARE · Cap: $1.63B
RMD
ResMed Inc
$238.97
-1.35%
HEALTHCARE · Cap: $33.61B
Smart Verdict
WallStSmart Research — data-driven comparison
ResMed Inc generates 5197% more annual revenue ($5.65B vs $106.73M). RMD leads profitability with a 27.0% profit margin vs -140.4%. RMD earns a higher WallStSmart Score of 67/100 (B-).
KMTS
Avoid28
out of 100
Grade: F
RMD
Strong Buy67
out of 100
Grade: B-
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Intrinsic value data unavailable for KMTS.
Margin of Safety
-21.1%
Fair Value
$214.32
Current Price
$238.97
$24.65 premium
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Revenue surging 59.9% year-over-year
Strong operational efficiency at 30.9%
Safe zone — low bankruptcy risk
Every $100 of equity generates 23 in profit
Keeps 27 of every $100 in revenue as profit
Conservative balance sheet, low leverage
Generating 1.6B in free cash flow
Areas to Watch
0.0% earnings growth
Smaller company, higher risk/reward
ROE of -50.3% — below average capital efficiency
Negative free cash flow — burning cash
2.4% earnings growth
Comparative Analysis Report
WallStSmart ResearchBull Case : KMTS
The strongest argument for KMTS centers on Revenue Growth. Revenue growth of 59.9% demonstrates continued momentum.
Bull Case : RMD
The strongest argument for RMD centers on Operating Margin, Altman Z-Score, Return on Equity. Profitability is solid with margins at 27.0% and operating margin at 30.9%. PEG of 1.29 suggests the stock is reasonably priced for its growth.
Bear Case : KMTS
The primary concerns for KMTS are EPS Growth, Market Cap, Return on Equity.
Bear Case : RMD
The primary concerns for RMD are EPS Growth.
Key Dynamics to Monitor
KMTS profiles as a hypergrowth stock while RMD is a mature play — different risk/reward profiles.
KMTS is growing revenue faster at 59.9% — sustainability is the question.
RMD generates stronger free cash flow (1.6B), providing more financial flexibility.
Monitor MEDICAL INSTRUMENTS & SUPPLIES industry trends, competitive dynamics, and regulatory changes.
Bottom Line
RMD scores higher overall (67/100 vs 28/100), backed by strong 27.0% margins. Both earn "Strong Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Kestra Medical Technologies, Ltd. Common Stock
HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES · USA
Kestra Medical Technologies, Ltd. is a wearable medical device and digital healthcare company. The company is headquartered in Kirkland, Washington.
Visit Website →ResMed Inc
HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES · USA
ResMed is a San Diego, California-based medical equipment company. It primarily provides cloud-connectable medical devices for the treatment of sleep apnea (such as CPAP devices and masks), chronic obstructive pulmonary disease (COPD), and other respiratory conditions.
Visit Website →Compare with Other MEDICAL INSTRUMENTS & SUPPLIES Stocks
Want to dig deeper into these stocks?